551 related articles for article (PubMed ID: 22634127)
41. Clinicopathologic characteristics and long-term prognosis of intraductal papillary neoplasm of the bile duct: a retrospective study.
Wu X; Li B; Zheng C
Eur J Med Res; 2023 Mar; 28(1):132. PubMed ID: 36945047
[TBL] [Abstract][Full Text] [Related]
42. [Intraductal papillary neoplasms of the bile duct (IPNB). Diagnostic criteria, carcinogenesis and differential diagnostics].
Schlitter AM; Klöppel G; Esposito I
Pathologe; 2013 Nov; 34 Suppl 2():235-40. PubMed ID: 24196621
[TBL] [Abstract][Full Text] [Related]
43. Hepatic intraductal oncocytic papillary carcinoma.
Martin RC; Klimstra DS; Schwartz L; Yilmaz A; Blumgart LH; Jarnagin W
Cancer; 2002 Nov; 95(10):2180-7. PubMed ID: 12412172
[TBL] [Abstract][Full Text] [Related]
44. Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma.
Sasaki R; Takeda Y; Funato O; Nitta H; Kawamura H; Uesugi N; Sugai T; Wakabayashi G; Ohkohchi N
World J Surg; 2007 Sep; 31(9):1788-1796. PubMed ID: 17647056
[TBL] [Abstract][Full Text] [Related]
45. A statement by the Japan-Korea expert pathologists for future clinicopathological and molecular analyses toward consensus building of intraductal papillary neoplasm of the bile duct through several opinions at the present stage.
Nakanuma Y; Jang KT; Fukushima N; Furukawa T; Hong SM; Kim H; Lee KB; Zen Y; Jang JY; Kubota K
J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):181-187. PubMed ID: 29272078
[TBL] [Abstract][Full Text] [Related]
46. Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications.
Yamaguchi K; Chijiiwa K; Saiki S; Shimizu S; Takashima M; Tanaka M
Hepatogastroenterology; 1997; 44(17):1256-61. PubMed ID: 9356836
[TBL] [Abstract][Full Text] [Related]
47. Morphological classification of intraductal papillary neoplasm of the bile duct.
Ying S; Ying M; Liang W; Wang Z; Wang Q; Chen F; Xiao W
Eur Radiol; 2018 Apr; 28(4):1568-1578. PubMed ID: 29138880
[TBL] [Abstract][Full Text] [Related]
48. Procedure of extended hilar bile duct resection and its application for hilar cholangiocarcinoma.
Shimada H; Endo I; Fujii Y; Kunihiro O; Tanaka K; Misuta K; Togo S
Hepatogastroenterology; 2002; 49(44):300-5. PubMed ID: 11995438
[TBL] [Abstract][Full Text] [Related]
49. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is a marker that predicts presence of invasion in papillary biliary tumors.
Sasaki M; Sato Y
Hum Pathol; 2017 Apr; 62():152-159. PubMed ID: 28089541
[TBL] [Abstract][Full Text] [Related]
50. Intraoperative frozen section diagnosis of bile duct margin for extrahepatic cholangiocarcinoma.
Shiraki T; Kuroda H; Takada A; Nakazato Y; Kubota K; Imai Y
World J Gastroenterol; 2018 Mar; 24(12):1332-1342. PubMed ID: 29599608
[TBL] [Abstract][Full Text] [Related]
51. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
Higashi M; Yonezawa S; Ho JJ; Tanaka S; Irimura T; Kim YS; Sato E
Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510
[TBL] [Abstract][Full Text] [Related]
52. Clinicopathological Aspects and Diagnostic Problems in Patients with Intraductal Papillary Neoplasm of the Bile Duct.
Nanashima A; Imamura N; Sumida Y; Hiyoshi M; Hamada T; Nagayasu T
Anticancer Res; 2018 Apr; 38(4):2343-2352. PubMed ID: 29599359
[TBL] [Abstract][Full Text] [Related]
53. Usefulness of Preoperative
Ikeno Y; Seo S; Yamamoto G; Nakamoto Y; Uemoto Y; Fuji H; Yoshino K; Yoh T; Taura K; Uemoto S
Anticancer Res; 2018 Jun; 38(6):3677-3682. PubMed ID: 29848727
[TBL] [Abstract][Full Text] [Related]
54. [Intraductal papillary neoplasms of intrahepatic bile duct: a clinicopathologic study of 25 cases].
Chang XY; Li J; Ren XY; Zhou WX; Chen J
Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):243-7. PubMed ID: 27033387
[TBL] [Abstract][Full Text] [Related]
55. Intraductal papillary-mucinous neoplasms of the gastric and intestinal types may have less malignant potential than the pancreatobiliary type.
Takasu N; Kimura W; Moriya T; Hirai I; Takeshita A; Kamio Y; Nomura T
Pancreas; 2010 Jul; 39(5):604-10. PubMed ID: 20124938
[TBL] [Abstract][Full Text] [Related]
56. Hepatic intraductal oncocytic papillary carcinoma.
Cocieru A; Kesha K; El-Fanek H; Saldinger PF
Am J Surg; 2010 May; 199(5):e57-8. PubMed ID: 19944406
[TBL] [Abstract][Full Text] [Related]
57. Intraductal papillary neoplasm of the bile duct: review of updated clinicopathological and imaging characteristics.
Kim JR; Jang KT; Jang JY
Br J Surg; 2023 Aug; 110(9):1229-1240. PubMed ID: 37463281
[TBL] [Abstract][Full Text] [Related]
58. Intraductal papillary neoplasm of the bile duct.
Wan XS; Xu YY; Qian JY; Yang XB; Wang AQ; He L; Zhao HT; Sang XT
World J Gastroenterol; 2013 Dec; 19(46):8595-604. PubMed ID: 24379576
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic performance of CT and MRI in distinguishing intraductal papillary neoplasm of the bile duct from cholangiocarcinoma with intraductal papillary growth.
Liu Y; Zhong X; Yan L; Zheng J; Liu Z; Liang C
Eur Radiol; 2015 Jul; 25(7):1967-74. PubMed ID: 25716939
[TBL] [Abstract][Full Text] [Related]
60. Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma.
Ribero D; Amisano M; Lo Tesoriere R; Rosso S; Ferrero A; Capussotti L
Ann Surg; 2011 Nov; 254(5):776-81; discussion 781-3. PubMed ID: 22042470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
